lymphoma

(redirected from T-cell lymphoma)
Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

lym·pho·ma

 (lĭm-fō′mə)
n. pl. lym·pho·ma·ta (-mə-tə) or lym·pho·mas
1. Any of various malignant tumors that arise from the lymphocytic cells of the immune system.
2. Any of various cancers characterized by the development of such tumors, especially Hodgkin lymphoma and non-Hodgkin lymphoma.

lym·pho′ma·toid′, lym·pho′ma·tous (-təs) adj.

lymphoma

(lɪmˈfəʊmə)
n, pl -mata (-mətə) or -mas
(Pathology) any form of cancer of the lymph nodes. Also called: lymphosarcoma
lymˈphomatous, lymˈphomaˌtoid adj

lym•pho•ma

(lɪmˈfoʊ mə)

n., pl. -mas, -ma•ta (-mə tə)
a tumor arising from any of the cellular elements of lymph nodes.
[1870–75]
lym•pho′ma•toid`, adj.

lymphoma

a growth of lymphoid tissue that is commonly cancerous and typically enlarges the lymph nodes.
See also: Cancer
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.lymphoma - a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
cancer, malignant neoplastic disease - any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream
Hodgkin's disease - a malignant disorder in which there is progressive (but painless) enlargement of lymph tissue followed by enlargement of the spleen and liver
Translations
lymfom

lym·pho·ma

n. linfoma, neoplasma del tejido linfático.

lymphoma

n linfoma m; B cell — linfoma de células B; Hodgkin’s — linfoma (de) Hodgkin; mucosa-associated lymphoid tissue (MALT) — linfoma MALT, linfoma de tejido linfoide asociado a mucosas; non-Hodgkin’s — linfoma no Hodgkin; T cell — linfoma de células T
References in periodicals archive ?
M2 PHARMA-January 25, 2018-Adcetris Approved in Europe for CD30-Positive Cutaneous T-Cell Lymphoma after One Prior Systemic Therapy
While recent developments, such as immunotherapies, have turned the once fatal diagnosis of B-cell lymphoma into a curable condition, BBC News notes that T-cell lymphoma is much rarer and often more aggressive.
2,5) Consequently, primary cutaneous acral (CD8) + T-cell lymphoma has been added as a provisional entity in the 2016 revision of the World Health Organization classification of lymphoid neoplasms.
ECHELON-2 is a global phase 3 randomized trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in patients with previously untreated CD30-positive mature T-cell lymphoma (MTCL).
com)-- The report provides information on the therapeutic development based on the T-Cell Lymphoma across 45+ pipeline drugs and 40+ companies active in this field.
patients with cutaneous T-cell lymphoma or peripheral T-cell lymphoma is currently underway in Japan.
A Phase II clinical study of the agent in patients with cutaneous T-cell lymphoma or peripheral T-cell lymphoma is currently underway in Japan.
Compared with our patient group, higher rates of cutaneous NK/T-cell lymphomas such as extranodal NK/T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma (SPTCL) have been found in Korean and Japanese populations [22,23].
Type II enteropathy-associated T-cell lymphoma (Type II EATL) is only rarely reported in Asia, especially in Taiwan and is known to be associated with a high bowel perforation rate.
UKPRwire, Wed Jun 05 2013] Global Markets Direct's, 'Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
We also looked at exposure to immunomodulators and risk of T-cell lymphoma, the subtype we are most concerned about," Dr.
The company is testing drugs for cutaneous T-cell lymphoma and peripheral T-cell lymphoma, which are both types of non-Hodgkin's lymphoma.